Helowin Medical Technology
A manufacturer and provider of medical equipment
About Helowin Medical Technology
Zhejiang Helowin Medical Technology Co., Ltd. operates as a comprehensive high-tech enterprise focused on bridging the gap between doctors and patients through digital health solutions. Founded in 2006 by Chairman Sun Bin, the company has evolved from a developer of wireless intelligent data collection terminals to a multi-faceted provider of medical health big data cloud platforms and health service analytics.
Helowin's business strategy encompasses B2B, B2B2C, and B2C models, catering to a wide spectrum of users including government bodies, hospitals, grassroots medical institutions, and individuals. For its governmental and institutional clients, the company provides holistic smart medical and telemedicine solutions, which include the development of regional health information platforms designed to integrate various local health systems and improve the efficiency of public health services. The B2B2C model leverages a combination of wireless smart terminals, a big data cloud platform, AI-assisted diagnostics, and national-level telemedicine to extend medical services to the community level, supporting chronic disease management and early detection. For individual consumers (B2C), Helowin offers health management services through its cloud platform, utilizing proprietary algorithms and wearable devices.
The company's product portfolio is extensive, featuring a range of wireless intelligent wearable devices that have received Class II medical device production licenses. These devices can simultaneously monitor multiple physiological parameters such as ECG, blood pressure, blood oxygen, respiration, and body temperature. Complementing its hardware, Helowin has developed several software platforms, including an international telemedicine platform, the "995120" Health Cloud, a chronic disease management platform, and a regional ECG cloud. A key technological asset is its ECG automatic analysis and diagnosis algorithm, developed over 10 years and based on a 16T patient ECG database, capable of automatically diagnosing a wide array of cardiac conditions. This system aids grassroots medical institutions by providing rapid and precise AI-assisted diagnostics. Helowin has actively participated in national research projects and has established collaborations with major entities like Huawei and the China-Japan Friendship Hospital to enhance its service delivery.
Source: Dealroom company dataNews
Open roles
Helowin Medical Technology in its local ecosystem
The Helowin Medical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- HIHuaou Equity Investment
Series B and later5 investors entered at this stage
Hosen Capital- JCJuren Capital
- ECEastern Link Capital
GF Securities
New Hope Sichuan Venture Capital Fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Helowin Medical Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Helowin Medical Technology on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


